Optimizing Drug Positioning in IBD: Clinical Predictors, Biomarkers, and Practical Approaches to Personalized Therapy.

Biomedicines · 2026 · PMC12838568 · PMID 41595725

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

By contrast, corticosteroid-free clinical remission was achieved in 12.6% of patients treated with vedolizumab versus 21.8% of those receiving adalimumab, though this difference did not reach statistical significance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.